The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis
Authors:
- 10 October 2022
- journal article
- review article
- Published by Elsevier in The Lancet Psychiatry
- Vol. 9 (11) , 884-893
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (FKZ 01KG1508)
- China Scholarship Council
- Technische Universität München
- School of Medicine, University of Missouri
This publication has 42 references indexed in Scilit:
- International Consensus Study of Antipsychotic DosingAmerican Journal of Psychiatry, 2010
- Review: The biological basis of antipsychotic response in schizophreniaJournal of Psychopharmacology, 2009
- The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE studySchizophrenia Research, 2008
- Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia ResearchSchizophrenia Bulletin, 2008
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic DisordersCNS Drugs, 2008
- Metabolic effects of olanzapine and risperidone in patients with psychotic disordersInternational Journal of Psychiatry in Clinical Practice, 2008
- Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs ChlorpromazineNeuropsychopharmacology, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Prediction of Response to Phenothiazines in SchizophreniaArchives of General Psychiatry, 1972
- PREDICTING RESPONSE TO PHENOTHIAZINESJournal of Nervous & Mental Disease, 1968